Effects of HIV-1 protease on cellular functions and their potential applications in antiretroviral therapy

Human Immunodeficiency Virus Type 1 (HIV-1) protease inhibitors (PIs) are the most potent class of drugs in antiretroviral therapies. However, viral drug resistance to PIs could emerge rapidly thus reducing the effectiveness of those drugs. Of note, all current FDA-approved PIs are competitive inhib...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Hailiu, Nkeze, Joseph, Zhao, Richard Y
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3490751/
https://www.ncbi.nlm.nih.gov/pubmed/22971934
http://dx.doi.org/10.1186/2045-3701-2-32

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3490751/
https://www.ncbi.nlm.nih.gov/pubmed/22971934
http://dx.doi.org/10.1186/2045-3701-2-32

Ejemplares similares